The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Vinpocetine Market Research Report 2025

Global Vinpocetine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1411030

No of Pages : 96

Synopsis
Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis
Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).
The global Vinpocetine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In the US market, the major manufacturers are Gedeon Richter, Runhong, Sun Pharma, WZT, Pude, Welman and Zhitong.
This report aims to provide a comprehensive presentation of the global market for Vinpocetine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vinpocetine.
Report Scope
The Vinpocetine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vinpocetine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vinpocetine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gedeon Richter
Runhong
Sun Pharma
WZT
PUDE
Welman
ZhiTong
Liaoning Zhiying
COVEX
Northeast Pharma
Micro Labs
Segment by Type
Tablet
Injection
Segment by Application
Household
Hospital
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vinpocetine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vinpocetine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Vinpocetine Market Overview
1.1 Product Overview and Scope of Vinpocetine
1.2 Vinpocetine Segment by Type
1.2.1 Global Vinpocetine Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Injection
1.3 Vinpocetine Segment by Application
1.3.1 Global Vinpocetine Market Value by Application: (2024-2030)
1.3.2 Household
1.3.3 Hospital
1.4 Global Vinpocetine Market Size Estimates and Forecasts
1.4.1 Global Vinpocetine Revenue 2019-2030
1.4.2 Global Vinpocetine Sales 2019-2030
1.4.3 Global Vinpocetine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vinpocetine Market Competition by Manufacturers
2.1 Global Vinpocetine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vinpocetine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vinpocetine Average Price by Manufacturers (2019-2024)
2.4 Global Vinpocetine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vinpocetine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vinpocetine, Product Type & Application
2.7 Vinpocetine Market Competitive Situation and Trends
2.7.1 Vinpocetine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vinpocetine Players Market Share by Revenue
2.7.3 Global Vinpocetine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vinpocetine Retrospective Market Scenario by Region
3.1 Global Vinpocetine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vinpocetine Global Vinpocetine Sales by Region: 2019-2030
3.2.1 Global Vinpocetine Sales by Region: 2019-2024
3.2.2 Global Vinpocetine Sales by Region: 2025-2030
3.3 Global Vinpocetine Global Vinpocetine Revenue by Region: 2019-2030
3.3.1 Global Vinpocetine Revenue by Region: 2019-2024
3.3.2 Global Vinpocetine Revenue by Region: 2025-2030
3.4 North America Vinpocetine Market Facts & Figures by Country
3.4.1 North America Vinpocetine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vinpocetine Sales by Country (2019-2030)
3.4.3 North America Vinpocetine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vinpocetine Market Facts & Figures by Country
3.5.1 Europe Vinpocetine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vinpocetine Sales by Country (2019-2030)
3.5.3 Europe Vinpocetine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vinpocetine Market Facts & Figures by Country
3.6.1 Asia Pacific Vinpocetine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vinpocetine Sales by Country (2019-2030)
3.6.3 Asia Pacific Vinpocetine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vinpocetine Market Facts & Figures by Country
3.7.1 Latin America Vinpocetine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vinpocetine Sales by Country (2019-2030)
3.7.3 Latin America Vinpocetine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vinpocetine Market Facts & Figures by Country
3.8.1 Middle East and Africa Vinpocetine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vinpocetine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vinpocetine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vinpocetine Sales by Type (2019-2030)
4.1.1 Global Vinpocetine Sales by Type (2019-2024)
4.1.2 Global Vinpocetine Sales by Type (2025-2030)
4.1.3 Global Vinpocetine Sales Market Share by Type (2019-2030)
4.2 Global Vinpocetine Revenue by Type (2019-2030)
4.2.1 Global Vinpocetine Revenue by Type (2019-2024)
4.2.2 Global Vinpocetine Revenue by Type (2025-2030)
4.2.3 Global Vinpocetine Revenue Market Share by Type (2019-2030)
4.3 Global Vinpocetine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vinpocetine Sales by Application (2019-2030)
5.1.1 Global Vinpocetine Sales by Application (2019-2024)
5.1.2 Global Vinpocetine Sales by Application (2025-2030)
5.1.3 Global Vinpocetine Sales Market Share by Application (2019-2030)
5.2 Global Vinpocetine Revenue by Application (2019-2030)
5.2.1 Global Vinpocetine Revenue by Application (2019-2024)
5.2.2 Global Vinpocetine Revenue by Application (2025-2030)
5.2.3 Global Vinpocetine Revenue Market Share by Application (2019-2030)
5.3 Global Vinpocetine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Gedeon Richter
6.1.1 Gedeon Richter Corporation Information
6.1.2 Gedeon Richter Description and Business Overview
6.1.3 Gedeon Richter Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Gedeon Richter Vinpocetine Product Portfolio
6.1.5 Gedeon Richter Recent Developments/Updates
6.2 Runhong
6.2.1 Runhong Corporation Information
6.2.2 Runhong Description and Business Overview
6.2.3 Runhong Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Runhong Vinpocetine Product Portfolio
6.2.5 Runhong Recent Developments/Updates
6.3 Sun Pharma
6.3.1 Sun Pharma Corporation Information
6.3.2 Sun Pharma Description and Business Overview
6.3.3 Sun Pharma Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sun Pharma Vinpocetine Product Portfolio
6.3.5 Sun Pharma Recent Developments/Updates
6.4 WZT
6.4.1 WZT Corporation Information
6.4.2 WZT Description and Business Overview
6.4.3 WZT Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 WZT Vinpocetine Product Portfolio
6.4.5 WZT Recent Developments/Updates
6.5 PUDE
6.5.1 PUDE Corporation Information
6.5.2 PUDE Description and Business Overview
6.5.3 PUDE Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 PUDE Vinpocetine Product Portfolio
6.5.5 PUDE Recent Developments/Updates
6.6 Welman
6.6.1 Welman Corporation Information
6.6.2 Welman Description and Business Overview
6.6.3 Welman Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Welman Vinpocetine Product Portfolio
6.6.5 Welman Recent Developments/Updates
6.7 ZhiTong
6.6.1 ZhiTong Corporation Information
6.6.2 ZhiTong Description and Business Overview
6.6.3 ZhiTong Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ZhiTong Vinpocetine Product Portfolio
6.7.5 ZhiTong Recent Developments/Updates
6.8 Liaoning Zhiying
6.8.1 Liaoning Zhiying Corporation Information
6.8.2 Liaoning Zhiying Description and Business Overview
6.8.3 Liaoning Zhiying Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Liaoning Zhiying Vinpocetine Product Portfolio
6.8.5 Liaoning Zhiying Recent Developments/Updates
6.9 COVEX
6.9.1 COVEX Corporation Information
6.9.2 COVEX Description and Business Overview
6.9.3 COVEX Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 COVEX Vinpocetine Product Portfolio
6.9.5 COVEX Recent Developments/Updates
6.10 Northeast Pharma
6.10.1 Northeast Pharma Corporation Information
6.10.2 Northeast Pharma Description and Business Overview
6.10.3 Northeast Pharma Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Northeast Pharma Vinpocetine Product Portfolio
6.10.5 Northeast Pharma Recent Developments/Updates
6.11 Micro Labs
6.11.1 Micro Labs Corporation Information
6.11.2 Micro Labs Vinpocetine Description and Business Overview
6.11.3 Micro Labs Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Micro Labs Vinpocetine Product Portfolio
6.11.5 Micro Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vinpocetine Industry Chain Analysis
7.2 Vinpocetine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vinpocetine Production Mode & Process
7.4 Vinpocetine Sales and Marketing
7.4.1 Vinpocetine Sales Channels
7.4.2 Vinpocetine Distributors
7.5 Vinpocetine Customers
8 Vinpocetine Market Dynamics
8.1 Vinpocetine Industry Trends
8.2 Vinpocetine Market Drivers
8.3 Vinpocetine Market Challenges
8.4 Vinpocetine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’